In this episode, KGI President Sheldon Schuster chats with Mary Ellen Cosenza, who is a regulatory consultant with more than 30 years of senior leadership experience in the biopharmaceutical industry in the U.S., Europe, and emerging markets.
Most recently, she served as the Executive Director, U.S. Regulatory Affairs, at Amgen. During her 20-year tenure at Amgen, she led the International Emerging Markets Regulatory Department and served as an Executive Director of Global Regulatory Affairs and Safety. In addition to her leadership roles in Regulatory Affairs, she also served as the Senior Director of Toxicology at Amgen. Prior to joining Amgen, she served as a Principal Scientist for the Medical Research Division of American Cyanimid Company (now Pfizer).